Literature DB >> 32506600

Safety measures in dermatology help minimize spread of COVID-19.

Andy Goren1, Dipali Rathod2, George Kroumpouzos3,4, Mohammad Jafferany5, Mohamad Goldust6,7.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32506600      PMCID: PMC7300612          DOI: 10.1111/dth.13773

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   3.858


× No keyword cloud information.
Dear Editor, Health care providers can do a lot together to help reduce the risk of transmitting coronavirus disease 2019 (COVID‐19) within the communities they serve. , , As dermatologists, we need to practice effective safety measures as recommended by the World Health Organization (WHO); the Center for Disease Control and Prevention (CDC); the American Academy of Dermatology (AAD); and other local, state, national, and global health organizations while treating our patients amidst the COVID‐19 outbreak to reduce the risk of community transmission and protect our patients, partners, and staff. , , , Disinfection of practice is crucial. The WHO recommends the use of 70% ethyl alcohol to disinfect popular clinical areas between uses and sodium hypochlorite 0.5% to disinfect common surfaces. Common areas should be sanitized between patients and at the end of each day. Such areas include exam room tabletops, countertops, exam beds/tables, doorknobs, exam light buttons and handles, chairs and faucet handles, all bathroom surfaces, countertop surfaces and chairs in the reception area, all surfaces and chairs in the office, and all surfaces and countertops in the lab. Patients visiting outpatient dermatology clinics and inpatient departments should adhere to proper respiratory hygiene, that is, wear masks covering the nose and mouth areas, and any suspected COVID‐19‐infected patient or those with any mild respiratory illness should be referred to the respective departments and specialists. If a patient with respiratory symptoms is unable to reschedule, they should be provided with a mask and isolated in an examination room, and staff caring for the patient should be notified. Dermatologists in private practice need to review and reinforce infection control policies in their office and alert colleagues and the public to minimize the risk that arises when a patient with exposure to COVID‐19 visits the practice. For all patients, entry points should be limited. Patients should be advised to call from home to make their follow‐up appointment and not to stop at the front desk on their way out; this helps making the waiting area less crowded. As per recommendation of the AAD, practices should place additional hand sanitizers and wipes in all populated rooms in the clinic to prevent the spread of the coronavirus. Patients visiting dermatology facilities should not be allowed to take their masks off except for indications of severe facial lesions. Dermatologists and support staff should wear surgical caps, masks, gloves, goggles, and protective suits while at work and take off their personal protective equipment only after their work is over in a designated disposable area. Since the dermatologist and other office staff could be exposed to viral infections (eg, varicella, human papillomavirus, HIV, measles, and other viral exanthems) other than COVID‐19, this may pose a risk to the staff and immunosuppressed patients attending dermatology facilities, and employees and those concerned should receive appropriate vaccinations and testing to assess their immune status. Pregnant women and women of childbearing age should be particularly cognizant of these protocols and should be advised to visit a health center in case of only an absolute emergency. Safety measures that need to be stringently undertaken to protect both the patients and staff while working include before and after all patient contact, carrying out proper hand hygiene, that is, washing hands regularly with soap and hot water at least for 20 seconds, especially before eating, after visiting the bathroom, after touching or blowing the nose, sneezing, or coughing. Use of an alcohol‐based hand sanitizer with at least 60% to 70% alcohol content should be encouraged in case soap and water are not readily available. Cough etiquette includes mandatory use of a mask, or clean tissue, to cover nose and mouth while coughing or sneezing and appropriate disposal of such after use. Advice to avoid touching the eyes, nose, and mouth with unwashed hands also remains crucial. Minimizing unnecessary scheduling of nonemergent patients in the dermatology facilities and accommodating emergency cases and procedures through appointments along with frequent disinfection of popular clinical areas, as per guidelines provided by WHO and CDC, should help curb the spread of this COVID‐19 outbreak.

CONFLICT OF INTEREST

The authors declare no conflict of interest.
  9 in total

1.  The coronavirus (COVID-19) epidemic and patient safety.

Authors:  Dirk M Elston
Journal:  J Am Acad Dermatol       Date:  2020-02-16       Impact factor: 11.527

2.  Immunosuppressive treatment for systemic sclerosis-Therapeutic challenges during the COVID-19 pandemic.

Authors:  Leszek Blicharz; Joanna Czuwara; Zbigniew Samochocki; Mohamad Goldust; Małgorzata Olszewska; Lidia Rudnicka
Journal:  Dermatol Ther       Date:  2020-06-30       Impact factor: 3.858

3.  Fever with rash in COVID-19: viral exanthema or secondary lesions?

Authors:  M Goldust; A Abdelmaksoud; Z Shuang; C Xiang; A A Navarini
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-25       Impact factor: 9.228

4.  A dermatologist's perspective of the COVID-19 outbreak.

Authors:  Dedee F Murrell; Gulhima Arora; Lidia Rudnicka; Martin Kassir; Torello Lotti; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-06-23       Impact factor: 3.858

5.  Will teledermatology be the silver lining during and after COVID-19?

Authors:  Aseem Sharma; Veenu Jindal; Palvi Singla; Mohamad Goldust; Madhulika Mhatre
Journal:  Dermatol Ther       Date:  2020-06-04       Impact factor: 3.858

6.  Management of pregnant women infected with COVID-19.

Authors:  Yongwen Luo; Kai Yin
Journal:  Lancet Infect Dis       Date:  2020-03-24       Impact factor: 25.071

7.  Rational use of face masks in the COVID-19 pandemic.

Authors:  Shuo Feng; Chen Shen; Nan Xia; Wei Song; Mengzhen Fan; Benjamin J Cowling
Journal:  Lancet Respir Med       Date:  2020-03-20       Impact factor: 30.700

8.  Where do we stand as dermatologists in combat with COVID-19.

Authors:  Mohamad Goldust; Swathi Shivakumar; George Kroumpouzos; Dedee F Murrell; Simon M Mueller; Alexander A Navarini
Journal:  Dermatol Ther       Date:  2020-06-23       Impact factor: 3.858

9.  What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?

Authors:  Yusha Chen; Sushmita Pradhan; Siliang Xue
Journal:  J Am Acad Dermatol       Date:  2020-02-17       Impact factor: 11.527

  9 in total
  3 in total

Review 1.  Dermatology in a multidisciplinary approach with infectious disease and obstetric medicine against COVID-19.

Authors:  Rachel K Lim; Saisanjana Kalagara; Kenneth K Chen; Eleftherios Mylonakis; George Kroumpouzos
Journal:  Int J Womens Dermatol       Date:  2021-08-26

2.  Impact of COVID-19 pandemic on dermatology practices: Results of a web-based, global survey.

Authors:  Shashank Bhargava; Charles McKeever; George Kroumpouzos
Journal:  Int J Womens Dermatol       Date:  2020-10-12

3.  Dermatology and specialty rotations: COVID-19 may reemphasize the importance of internal medicine.

Authors:  Mohamad Goldust; Aseem Sharma; Dedee F Murrell; Negin Kazemi; Lidia Rudnicka; Martin Kassir; Alexander Navarini; Simon M Mueller
Journal:  Dermatol Ther       Date:  2020-08-11       Impact factor: 3.858

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.